Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.
CITATION STYLE
Mazoteras-Pardo, V., Becerro-De-Bengoa-Vallejo, R., Losa-Iglesias, M. E., Martínez-Jiménez, E. M., Calvo-Lobo, C., Romero-Morales, C., … Palomo-López, P. (2020). Qardioarm blood pressure monitoring in a population with type 2 diabetes: Validation study. Journal of Medical Internet Research, 22(7). https://doi.org/10.2196/19781
Mendeley helps you to discover research relevant for your work.